Belgium· BE-AMP-SAM585413-00
Lydisilka 3 mg - 14.2 mg
A drospirenone and estetrol product containing drospirenone, registered in Belgium by Estetra. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Drospirenone and estetrol is registered in 12 of 19 countries.
Countries holding a registration under ATC G03AA18 (drospirenone and estetrol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Drospirenone and estetrol · ATC G03AA18
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Drospirenone
- Manufacturer
- Estetra
- Country
- Belgium (BE)
- ATC code
- G03AA18
- ATC class
- Drospirenone and estetrol
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb4361838
- be_apb7731359
- be_apb4361812
- be_apb4361820
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Drospirenone and estetrol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandSlinda 4.0 mg, FilmtablettenExeltis Suisse SA
- CzechiaZLYNDAExeltis Czech s.r.o., Praha
- SpainSLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULAExeltis Healthcare S.L.
- United KingdomSlynd 4mg tabletsExeltis UK Ltd
- IrelandSlyndy 4 mg film-coated tabletsExeltis Healthcare S.L.
- IcelandSlindaExeltis Healthcare S.L.*
- NetherlandsSlinda 4 mg filmomhulde tablettenExeltis Healthcare S.L
- PolandSlindaExeltis Poland Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3f62dd9-20ad-46b5-8b6c-71cfcbb8222a GET /v1/drugs/c3f62dd9-20ad-46b5-8b6c-71cfcbb8222a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Lydisilka 3 mg - 14.2 mg",
"name_fr": "Lydisilka 3 mg - 14.2 mg",
"name_nl": "Lydisilka 3 mg - 14.2 mg",
"amp_code": "SAM585413-00",
"strengths": [
"3.0000",
"40.0000",
"40.0000",
"68.0000"
],
"pack_count": 4,
"substances": [
"Drospirenone",
"Estetrol Monohydrate",
"Estetrol",
"Lactose Monohydrate",
"Sodium Starch Glycolate",
"Placebo"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Drospirenone and Estetrol",
"authorisation_numbers": [
"EU/1/21/1548/002",
"EU/1/21/1548/003",
"EU/1/21/1548/001",
"EU/1/21/1548/004"
]
}See everything about drospirenone and estetrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.